Interaction of Brn3a and HIPK2 mediates transcriptional repression of sensory neuron survival

被引:87
作者
Wiggins, AK
Wei, GW
Doxakis, E
Wong, C
Tang, AA
Zang, K
Luo, EJ
Neve, RL
Reichardt, LF
Huang, EJ [1 ]
机构
[1] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA
[4] Vet Adm Med Ctr, San Francisco, CA 94121 USA
[5] Royal Dick Sch Vet Studies, Dpet Preclin Sci, Edinburgh EH9 12H, Midlothian, Scotland
[6] Harvard Univ, Sch Med, Dept Psychiat, Belmont, MA 02478 USA
关键词
D O I
10.1083/jcb.200406131
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The Pit1-Oct1-Unc86 domain (POU domain) transcription factor Brn3a controls sensory neuron survival by regulating the expression of Trk receptors and members of the Bcl-2 family. Loss of Brn3a leads to a dramatic increase in apoptosis and severe loss of neurons in sensory ganglia. Although recent evidence suggests that Brn3a-mediated transcription can be modified by additional cofactors, the exact mechanisms are not known. Here, we report that homeodomain interacting protein kinase 2 (HIPK2) is a pro-apoptotic transcriptional cofactor that suppresses Brn3a-mediated gene expression. HIPK2 interacts with Brn3a, promotes Brn3a binding to DNA, but suppresses Brn3a-dependent transcription of brn3a, trkA, and bcl-X-L. Overexpression of HIPK2 induces apoptosis in cultured sensory neurons. Conversely, targeted deletion of HIPK2 leads to increased expression of Brn3a, TrkA, and Bcl-x(L), reduced apoptosis and increases in neuron numbers in the trigeminal ganglion. Together, these data indicate that HIPK2, through regulation of Brn3a-dependent gene expression, is a critical component in the transcriptional machinery that controls sensory neuron survival.
引用
收藏
页码:257 / 267
页数:11
相关论文
共 47 条
[1]   Lineages and transcription factors in the specification of vertebrate primary sensory neurons [J].
Anderson, DJ .
CURRENT OPINION IN NEUROBIOLOGY, 1999, 9 (05) :517-524
[2]   p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor [J].
Budhram-Mahadeo, V ;
Morris, PJ ;
Smith, MD ;
Midgley, CA ;
Boxer, LM ;
Latchman, DS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (21) :15237-15244
[3]   The Brn-3a transcription factor inhibits the pro-apoptotic effect of p53 and enhances cell cycle arrest by differentially regulating the activity of the p53 target genes encoding Bax and p21CIP1/Waf1 [J].
Budram-Mahadeo, V ;
Morris, PJ ;
Latchman, DS .
ONCOGENE, 2002, 21 (39) :6123-6131
[4]   Neurotrophins and their receptors: A convergence point for many signalling pathways [J].
Chao, MV .
NATURE REVIEWS NEUROSCIENCE, 2003, 4 (04) :299-309
[5]   The homeodomain protein NK-3 recruits Groucho and a histone deacetylase complex to repress transcription [J].
Choi, CY ;
Kim, YH ;
Kwon, HJ ;
Kim, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (47) :33194-33197
[6]   Expression of multiple proteins within single primary cortical neurons using a replication deficient HSV vector [J].
Coopersmith, R ;
Neve, RL .
BIOTECHNIQUES, 1999, 27 (06) :1156-+
[7]   Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis [J].
D'Orazi, G ;
Cecchinelli, B ;
Bruno, T ;
Manni, I ;
Higashimoto, Y ;
Saito, S ;
Gostissa, M ;
Coen, S ;
Marchetti, A ;
Del Sal, G ;
Piaggio, G ;
Fanciulli, M ;
Appella, E ;
Soddu, S .
NATURE CELL BIOLOGY, 2002, 4 (01) :11-19
[8]   BAX is required for neuronal death after trophic factor deprivation and during development [J].
Deckwerth, TL ;
Elliott, JL ;
Knudson, CM ;
Johnson, EM ;
Snider, WD ;
Korsmeyer, SJ .
NEURON, 1996, 17 (03) :401-411
[9]   Defects in sensory axon growth precede neuronal death in Brn3a-deficient mice [J].
Eng, SR ;
Gratwick, K ;
Rhee, JM ;
Fedtsova, N ;
Gan, L ;
Turner, EE .
JOURNAL OF NEUROSCIENCE, 2001, 21 (02) :541-549
[10]   The BRN-3A transcription factor protects sensory but not sympathetic neurons from programmed cell death/apoptosis [J].
Ensor, E ;
Smith, MD ;
Latchman, DS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (07) :5204-5212